Allegis Investment Advisors’s Gilead Sciences GILD Stock Holding History

Allegis Investment Advisors’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-3,740	Closed	-$268K	–	220
2017 Q4	$268K	Buy	3,740 +206	+6%	+$15.6K	0.08%	185
2017 Q3	$286K	Buy	3,534 +288	+9%	+$22K	0.07%	208
2017 Q2	$230K	Buy	3,246 +164	+5%	+$10.9K	0.06%	234
2017 Q1	$209K	Sell	3,082 -9,842	-76%	-$692K	0.05%	237
2016 Q4	$925K	Buy	12,924 +428	+3%	+$31.8K	0.29%	95
2016 Q3	$989K	Buy	12,496 +531	+4%	+$43.1K	0.38%	91
2016 Q2	$984K	Sell	11,965 -943	-7%	-$83.7K	0.5%	70
2016 Q1	$1.19M	Buy	12,908 +997	+8%	+$89.9K	0.68%	49
2015 Q4	$1.21M	Buy	+11,911	New	+$1.24M	0.67%	36

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Allegis Investment Advisors's GILD Position: Q1 2018 in Review

Allegis Investment Advisors sold out of Gilead Sciences (GILD) in Q1 2018, closing a stake of 3,740 shares — an estimated $268K sold.

Allegis Investment Advisors first reported a position in GILD in Q4 2015 and held it in 9 quarters. The position peaked at $1.21M in Q4 2015. 1,564 funds tracked by Wall St. Rank hold GILD as of Q1 2018.

Allegis Investment Advisors reported no remaining Gilead Sciences position as of Q1 2018 after selling out during the quarter.
Allegis Investment Advisors sold 3,740 Gilead Sciences shares in Q1 2018, an estimated $268K.
Allegis Investment Advisors first reported a position in Gilead Sciences in Q4 2015 and held it in 9 quarters.
Allegis Investment Advisors's Gilead Sciences position peaked at $1.21M in Q4 2015.
1,564 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2018.

Based on Allegis Investment Advisors's 13F filing for Q1 2018, filed 24 Apr 2018.